These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32609979)

  • 1. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
    N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
    JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Amoxicillin for Pneumonia in Pakistan.
    Jehan F; Nisar I; Kerai S; Balouch B; Brown N; Rahman N; Rizvi A; Shafiq Y; Zaidi AKM
    N Engl J Med; 2020 Jul; 383(1):24-34. PubMed ID: 32609980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.
    Nkwopara E; Schmicker R; Mvalo T; Phiri M; Phiri A; Couasnon M; McCollum ED; Ginsburg AS
    BMJ Open Respir Res; 2019; 6(1):e000415. PubMed ID: 31548894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
    Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
    BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi.
    Ginsburg AS; May S
    Sci Rep; 2022 Mar; 12(1):3538. PubMed ID: 35241775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
    Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M;
    JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
    EMPIC Study Group
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.
    Awasthi S; Agarwal G; Kabra SK; Singhi S; Kulkarni M; More V; Niswade A; Pillai RM; Luke R; Srivastava NM; Suresh S; Verghese VP; Raghupathy P; Lodha R; Walter SD
    PLoS One; 2008 Apr; 3(4):e1991. PubMed ID: 18431478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
    McCollum ED; Brown SP; Nkwopara E; Mvalo T; May S; Ginsburg AS
    PLoS One; 2019; 14(6):e0214583. PubMed ID: 31220085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial.
    ; Tshefu A; Lokangaka A; Ngaima S; Engmann C; Esamai F; Gisore P; Ayede AI; Falade AG; Adejuyigbe EA; Anyabolu CH; Wammanda RD; Ejembi CL; Ogala WN; Gram L; Cousens S
    Lancet; 2015 May; 385(9979):1758-1766. PubMed ID: 25842223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
    Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.
    Bari A; Sadruddin S; Khan A; Khan Iu; Khan A; Lehri IA; Macleod WB; Fox MP; Thea DM; Qazi SA
    Lancet; 2011 Nov; 378(9805):1796-803. PubMed ID: 22078721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.
    Agarwal G; Awasthi S; Kabra SK; Kaul A; Singhi S; Walter SD;
    BMJ; 2004 Apr; 328(7443):791. PubMed ID: 15070633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community case management of lower chest indrawing pneumonia with oral amoxicillin in children in Kenya.
    Onono M; Abdi M; Mutai K; Asadhi E; Nyamai R; Okoth P; Qazi SA
    Acta Paediatr; 2018 Dec; 107 Suppl 471():44-52. PubMed ID: 30570795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
    Lodha R; Randev S; Kabra SK
    Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs.
    Ginsburg AS; Mvalo T; Phiri M; Gadama D; Chirombo C; Maliwichi M; Hwang J; May S
    J Glob Health; 2021 Mar; 11():04016. PubMed ID: 33791095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
    Jehan F; Nisar MI; Kerai S; Brown N; Balouch B; Hyder Z; Ambler G; Ginsburg AS; Zaidi AK
    BMC Infect Dis; 2016 Jan; 16():13. PubMed ID: 26758747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.